These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 31000444)

  • 21. Drug Reaction with Eosinophilia and Systemic Symptoms: A Complex Interplay between Drug, T Cells, and Herpesviridae.
    Ganeshanandan L; Lucas M
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS): How Far Have We Come?
    Martínez-Cabriales SA; Rodríguez-Bolaños F; Shear NH
    Am J Clin Dermatol; 2019 Apr; 20(2):217-236. PubMed ID: 30652265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
    Cardones AR
    Clin Dermatol; 2020; 38(6):702-711. PubMed ID: 33341203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with future development of type III polyglandular autoimmune syndrome.
    Morita C; Yanase T; Shiohara T; Aoyama Y
    BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30368475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs.
    Tashiro Y; Azukizawa H; Asada H; Niihara H; Morita E; Yamauchi T; Mizukawa Y; Kusakabe Y; Numazawa S; Izumi M; Sueki H; Watanabe H
    J Dermatol; 2019 Mar; 46(3):226-233. PubMed ID: 30663091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management.
    Wei BM; Fox LP; Kaffenberger BH; Korman AM; Micheletti RG; Mostaghimi A; Noe MH; Rosenbach M; Shinkai K; Kwah JH; Phillips EJ; Bolognia JL; Damsky W; Nelson CA
    J Am Acad Dermatol; 2024 May; 90(5):911-926. PubMed ID: 37516356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Facial pustules due to drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms may histopathologically mimic eosinophilic pustular folliculitis: A case report.
    Ogawa K; Mitsui Y; Miyamoto S; Nakamura-Nishimura Y; Nakanishi Y; Azukizawa H; Asada H
    J Cutan Pathol; 2019 May; 46(5):363-367. PubMed ID: 30666704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late-onset interstitial nephritis in a patient with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    Higashi Y; Baba N; Yoshimine H; Sakaguchi I; Kanekura T
    J Dermatol; 2020 Feb; 47(2):174-177. PubMed ID: 31840853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemokines in Severe Cutaneous Adverse Reactions (SCARs).
    Miyagawa F; Asada H
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34204146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DRESS/DiHS syndrome induced by Propylthiouracil: a case report.
    Shen Q; Wang Q; Zang H; Yu L; Cong X; Chen X; Chen L
    BMC Endocr Disord; 2023 Jan; 23(1):22. PubMed ID: 36691013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-reaction eosinophilia and systemic symptoms and drug-induced hypersensitivity syndrome.
    Fernando SL
    Australas J Dermatol; 2014 Feb; 55(1):15-23. PubMed ID: 23866082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shock state: an unrecognized and underestimated presentation of drug reaction with eosinophilia and systemic symptoms.
    Kimmoun A; Dubois E; Perez P; Barbaud A; Levy B
    Shock; 2013 Nov; 40(5):387-91. PubMed ID: 24088996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome: clinical features of 27 patients.
    Avancini J; Maragno L; Santi CG; Criado PR
    Clin Exp Dermatol; 2015 Dec; 40(8):851-9. PubMed ID: 26271788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmacytoid dendritic cells (pDCs) and regulatory T (Treg) cells may be the key to viral reactivation in drug-induced hypersensitivity syndrome (DIHS).
    Chen YC; Rosenblum MD; Shinkai K
    J Am Acad Dermatol; 2016 Jun; 74(6):1288-9. PubMed ID: 27185444
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug reaction with eosinophilia and systemic symptoms, or virus reactivation with eosinophilia and systemic symptoms as a manifestation of immune reconstitution inflammatory syndrome in a patient with HIV?
    Almudimeegh A; Rioux C; Ferrand H; Crickx B; Yazdanpanah Y; Descamps V
    Br J Dermatol; 2014 Oct; 171(4):895-8. PubMed ID: 24773172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features of drug-induced hypersensitivity syndrome to BRAF inhibitors with and without previous immune checkpoint inhibition: a review.
    Maloney NJ; Rana J; Yang JJ; Zaba LC; Kwong BY
    Support Care Cancer; 2022 Mar; 30(3):2839-2851. PubMed ID: 34546454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pustular-type drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to carbamazepine with systemic muscle involvement.
    Matsuda H; Saito K; Takayanagi Y; Okazaki T; Kashima K; Ishikawa K; Kai Y; Takeo N; Hatano Y; Okamoto O; Fujiwara S
    J Dermatol; 2013 Feb; 40(2):118-22. PubMed ID: 23216243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in understanding of the pathogenesis and therapeutic implications of drug reaction with eosinophilia and systemic symptoms: an updated review.
    Chen CB; Hung WK; Wang CW; Lee CC; Hung SI; Chung WH
    Front Med (Lausanne); 2023; 10():1187937. PubMed ID: 37457584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of human herpes virus 6 receptor CD134/OX40 in skin lesions of patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    Lee ES; Kiuchi Y; Inomata N; Sueki H
    J Dermatol; 2023 Mar; 50(3):387-392. PubMed ID: 36121111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug reaction with eosinophilia and systemic symptoms (DRESS): A histopathology based analysis.
    Sasidharanpillai S; Govindan A; Riyaz N; Binitha MP; Muhammed K; Khader A; Reena Mariyath OK; Simin M; Subin K
    Indian J Dermatol Venereol Leprol; 2016; 82(1):28-36. PubMed ID: 26728807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.